HOME >> BIOLOGY >> NEWS
Thinking big about things small

WASHINGTON -- Nanotechnologythe so-called science of the smallis raising some really big questions about the adequacy of the current federal oversight system. The Environmental Protection Agency (EPA) is grappling with understanding the jurisdiction and applicability of major laws, like the Toxic Substances Control Act (TSCA) and the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), with respect to nanotechnology. The Food and Drug Administration (FDA) is evaluating the effectiveness of the agencys regulatory approaches and authorities to meet the potential unique challenges presented by the use of nanomaterials in FDA-regulated products, and the agency expects to issue its findings in July 2007.

A new report by former EPA official Mark Greenwood, Thinking Big About Things Small: Creating an Effective Oversight System for Nanotechnology, urges policymakers to focus more attention on how core assumptions about risk assessment and risk management that underlie existing health and environmental regulations will translate from the macro world to the nano world. It also emphasizes that how the government ultimately oversees nanotechnology will have major impacts on business strategies, intellectual property, and the evolving structure of the industry. It argues that these issues should be discussed now, in the early stages of commercialization, rather than later.

A panel of speakers including Mr. Greenwood, Stephen Harper of Intel Corporation and Richard Denison of Environmental Defense will examine the reports conclusions at a program organized by the Project on Emerging Nanotechnologies. The event and live webcast will take place on Wednesday, March 14th at 10:00 a.m. in the Board Room on the 6th Floor of the Woodrow Wilson International Center for Scholars (www.wilsoncenter.org/directions).

Mr. Greenwood, who is currently a partner in the law firm Ropes & Gray, worked fo
'"/>

Contact: Julia Moore
julia.moore@wilsoncenter.org
202-691-4025
Project on Emerging Nanotechnologies
7-Mar-2007


Page: 1 2

Related biology news :

1. Thinking with the spinal cord?
2. Thinking the pain away? Study shows the brains painkillers may cause placebo effect
3. Thinking small: Texas A&M team creates lab-on-a-chip
4. Satellite tracking will help answer questions about penguin travels
5. White blood cells are picky about sugar
6. Study provides new data about the laws governing embryo development in organisms
7. Stressed-out African naked mole-rats may provide clues about human infertility
8. New findings challenge established views about human genome
9. Scientists concerned about effects of global warming on infectious diseases
10. Jet lag: Its all about chemical reactions in cells
11. Fly and worm models to teach researchers about human biology and medicine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: